Reactive astrocytes are reported to use NOX signaling to stimulate Lcn2 expression and secretion, and blocking astrocytic NHE1 activity promotes the reduction of Lcn2-mediated neurotoxicity after stroke [33]. The gene discussed is SLC9A1; the disease is stroke disorder.